Nicholas Focil

Nicholas Focil is the founder and CEO of FOMAT Medical Research- an Integrated Research Organization with over 10 years of experience conducting clinical research in a wide variety of therapeutic areas. As CEO of a medical research company, Nicholas aims to diversify clinical trials, bring innovative healthcare to underrepresented populations, and ensure that high-quality data is contributed to the scientific community to create better treatments. Due to his efforts in empowering patients and diversifying clinical trials, University of California Riverside, his alma mater, featured Nicholas in their Spring 2022 inaugural list recognizing 40 remarkable alumni under the age of 40. Nicholas is currently chairman and co-founder of AlzWell, an app chosen by the Northern California MIT Healthcare Association as a top 100 healthcare startup (and is part of the Plug and Play ecosystem). Nicholas is an Executive Board Member of hyperCORE International, the second-largest research organization in the world. He has served as a member of both the Innovation Steering Committee of ACRP and Forbes Los Angeles Business Council. Over the past 15 years, Nicholas has contributed to numerous publications, held a variety of board member assignments, and been honored with many speaking engagements within the scientific and business fields.